These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 10209286)

  • 41. Site-saturation mutagenesis and three-dimensional modelling of ROB-1 define a substrate binding role of Ser130 in class A beta-lactamases.
    Juteau JM; Billings E; Knox JR; Levesque RC
    Protein Eng; 1992 Oct; 5(7):693-701. PubMed ID: 1480622
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Replacement of lysine 234 affects transition state stabilization in the active site of beta-lactamase TEM1.
    Lenfant F; Labia R; Masson JM
    J Biol Chem; 1991 Sep; 266(26):17187-94. PubMed ID: 1910040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-function analysis of alpha-helix H4 using PSE-4 as a model enzyme representative of class A beta-lactamases.
    Savoie A; Sanschagrin F; Palzkill T; Voyer N; Levesque RC
    Protein Eng; 2000 Apr; 13(4):267-74. PubMed ID: 10810158
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A model for the secondary structure of beta-lactamases.
    Bunster M; Cid H
    FEBS Lett; 1984 Oct; 175(2):267-74. PubMed ID: 6434348
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Interaction of beta-lactamase inhibitors with various beta-lactamases.
    Cullmann W
    Chemotherapy; 1990; 36(3):200-8. PubMed ID: 2159863
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Circularly permuted beta-lactamase from Staphylococcus aureus PC1.
    Pieper U; Hayakawa K; Li Z; Herzberg O
    Biochemistry; 1997 Jul; 36(29):8767-74. PubMed ID: 9220963
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Refined crystal structure of beta-lactamase from Staphylococcus aureus PC1 at 2.0 A resolution.
    Herzberg O
    J Mol Biol; 1991 Feb; 217(4):701-19. PubMed ID: 2005620
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of residues critical for metallo-beta-lactamase function by codon randomization and selection.
    Materon IC; Palzkill T
    Protein Sci; 2001 Dec; 10(12):2556-65. PubMed ID: 11714924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Raman crystallographic studies of the intermediates formed by Ser130Gly SHV, a beta-lactamase that confers resistance to clinical inhibitors.
    Helfand MS; Taracila MA; Totir MA; Bonomo RA; Buynak JD; van den Akker F; Carey PR
    Biochemistry; 2007 Jul; 46(29):8689-99. PubMed ID: 17595114
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of four beta-lactamases produced by Staphylococcus aureus.
    Zygmunt DJ; Stratton CW; Kernodle DS
    Antimicrob Agents Chemother; 1992 Feb; 36(2):440-5. PubMed ID: 1605608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. beta-Lactamase-catalyzed hydrolysis of acyclic depsipeptides and acyl transfer to specific amino acid acceptors.
    Pratt RF; Govardhan CP
    Proc Natl Acad Sci U S A; 1984 Mar; 81(5):1302-6. PubMed ID: 6424114
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Avibactam and inhibitor-resistant SHV β-lactamases.
    Winkler ML; Papp-Wallace KM; Taracila MA; Bonomo RA
    Antimicrob Agents Chemother; 2015 Jul; 59(7):3700-9. PubMed ID: 25691639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Clinical inhibitor-resistant mutants of the beta-lactamase TEM-1 at amino-acid position 69. Kinetic analysis and molecular modelling.
    Chaibi EB; Péduzzi J; Farzaneh S; Barthélémy M; Sirot D; Labia R
    Biochim Biophys Acta; 1998 Jan; 1382(1):38-46. PubMed ID: 9507060
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The role of OXA-1 beta-lactamase Asp(66) in the stabilization of the active-site carbamate group and in substrate turnover.
    Leonard DA; Hujer AM; Smith BA; Schneider KD; Bethel CR; Hujer KM; Bonomo RA
    Biochem J; 2008 Mar; 410(3):455-62. PubMed ID: 18031291
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Inhibition of TEM-2 beta-lactamase from Escherichia coli by clavulanic acid: observation of intermediates by electrospray ionization mass spectrometry.
    Brown RP; Aplin RT; Schofield CJ
    Biochemistry; 1996 Sep; 35(38):12421-32. PubMed ID: 8823177
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Synthesis of new C-6 alkyliden penicillin derivatives as beta-lactamase inhibitors.
    Di Giacomo B; Tarzia G; Bedini A; Gatti G; Bartoccini F; Balsamini C; Tontini A; Baffone W; Di Modugno E; Felici A
    Farmaco; 2002 Apr; 57(4):273-83. PubMed ID: 11989807
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of disulfide-bond introduction on the activity and stability of the extended-spectrum class A beta-lactamase Toho-1.
    Shimizu-Ibuka A; Matsuzawa H; Sakai H
    Biochim Biophys Acta; 2006 Aug; 1764(8):1349-55. PubMed ID: 16890032
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nucleotide sequence and expression of the beta-lactamase gene from Staphylococcus aureus plasmid pI258 in Escherichia coli, Bacillus subtilis, and Staphylococcus aureus.
    Wang PZ; Novick RP
    J Bacteriol; 1987 Apr; 169(4):1763-6. PubMed ID: 3104315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SHV-type beta-lactamases.
    Tzouvelekis LS; Bonomo RA
    Curr Pharm Des; 1999 Nov; 5(11):847-64. PubMed ID: 10539992
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.